218 related articles for article (PubMed ID: 16355216)
1. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
Wu H; Chen Y; Liang J; Shi B; Wu G; Zhang Y; Wang D; Li R; Yi X; Zhang H; Sun L; Shang Y
Nature; 2005 Dec; 438(7070):981-7. PubMed ID: 16355216
[TBL] [Abstract][Full Text] [Related]
2. Hormones and cancer.
Shang Y
Cell Res; 2007 Apr; 17(4):277-9. PubMed ID: 17426695
[No Abstract] [Full Text] [Related]
3. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
Shang Y
Nat Rev Cancer; 2006 May; 6(5):360-8. PubMed ID: 16633364
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
[TBL] [Abstract][Full Text] [Related]
5. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
Bläuer M; Heinonen PK; Rovio P; Ylikomi T
Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study.
Gielen SC; Kühne LC; Ewing PC; Blok LJ; Burger CW
Endocr Relat Cancer; 2005 Dec; 12(4):1037-49. PubMed ID: 16322341
[TBL] [Abstract][Full Text] [Related]
8. [Tamoxifen and endometrial cancer].
Salamanca-Gómez F
Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554
[No Abstract] [Full Text] [Related]
9. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
10. The endometrial effects of SERMs.
Cano A; Hermenegildo C
Hum Reprod Update; 2000; 6(3):244-54. PubMed ID: 10874569
[TBL] [Abstract][Full Text] [Related]
11. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells.
Sakamoto T; Eguchi H; Omoto Y; Ayabe T; Mori H; Hayashi S
Mol Cell Endocrinol; 2002 Jun; 192(1-2):93-104. PubMed ID: 12088871
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
Lian Z; De Luca P; Di Cristofano A
J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
[TBL] [Abstract][Full Text] [Related]
15. MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.
Nagy E; Gajjar KB; Patel II; Taylor S; Martin-Hirsch PL; Stringfellow HF; Martin FL; Phillips DH
Br J Cancer; 2014 Jun; 110(12):2874-80. PubMed ID: 24853176
[TBL] [Abstract][Full Text] [Related]
16. Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.
Ignatov T; Eggemann H; Semczuk A; Smith B; Bischoff J; Roessner A; Costa SD; Kalinski T; Ignatov A
Am J Obstet Gynecol; 2010 Dec; 203(6):595.e9-16. PubMed ID: 20965484
[TBL] [Abstract][Full Text] [Related]
17. The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen.
Wang S; Somisetty VS; Bai B; Chernukhin I; Niskanen H; Kaikkonen MU; Bellet M; Carroll JS; Hurtado A
Oncogene; 2020 Oct; 39(40):6300-6312. PubMed ID: 32843722
[TBL] [Abstract][Full Text] [Related]
18. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
19. Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.
Gielen SC; Santegoets LA; Kühne LC; Van Ijcken WF; Boers-Sijmons B; Hanifi-Moghaddam P; Helmerhorst TJ; Blok LJ; Burger CW
Reprod Sci; 2007 Oct; 14(7):646-54. PubMed ID: 18000226
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.
Ferguson SE; Olshen AB; Viale A; Awtrey CS; Barakat RR; Boyd J
Gynecol Oncol; 2004 Feb; 92(2):719-25. PubMed ID: 14766275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
